Neck PainNCT06480851
Effectiveness of Percutaneous Neuromodulation in the Treatment of Cervical Pain in University Students.
A study testing Ecoguided Percutaneous Neuromodulation in people with Neck Pain, run by CEU San Pablo University at 1 site in Spain.
Trial summary
A non-randomized experimental study will be conducted to investigate the effect of Ecoguided Percutaneous Neuromodulation on patients with and without neck pain in college students. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Neck Pain
- What is being tested?
- Ecoguided Percutaneous Neuromodulation
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 siteSpain
- Study dates
- 31 Aug 2024to 30 Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Current Cervical Pain on a Visual Analog Scale (VAS) greater than 3.
- Neck pain in the last 12 weeks, and no treatment has been performed.
- Disability index of 8% or more on the Neck Disability Index.
- That they have undergone treatment.
Who cannot join
- Neck pain associated with vertigo.
- Osteoporosis (control X-ray).
- Diagnosed psychological disorders.
- Vertebral fractures (control X-ray).
- Tumors.
- Diagnosed metabolic diseases.
- Neck surgery.
- Belonephobia.
Trial locations and contacts
1 site in 1 country.
About this study
A non-randomized experimental study will be conducted to investigate the effect of Ecoguided Percutaneous Neuromodulation on patients with and without neck pain in college students. The sample will be collected in a non-probabilistic way at convenience among the students at the San Pablo-CEU University, with a sample that will be divided into two groups: group 1 (G1) with neck pain and group 2 (G2).
- Conditions
- Neck Pain
- Being tested
- Ecoguided Percutaneous Neuromodulation
- Keywords
- pain, Ecoguided Percutaneous Neuromodulation
- Medical subject headings
- Neck Pain, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ecoguided Percutaneous NeuromodulationProcedure or surgery
Ecoguided Percutaneous Neuromodulation over the posterior branch of the cervical multifidus, for 10 minutes, with a frequency of 10 HZ.
| Study group | Role | What they receive |
|---|---|---|
| Neck Pain Group | Experimental | Not described Receives: Procedure: Ecoguided Percutaneous Neuromodulation |
| Non Neck Pain Group | Active comparator | Not described Receives: Procedure: Ecoguided Percutaneous Neuromodulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain threshold
Portable hand pressure algometer (FPX 50/220, Wagner Instruments, Greenwich, USA), measured in kg / cm² (kilogram per centimeter squared).
Measured: up to 1 Week
Secondary outcomes (18)
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Measured: Baseline
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Measured: after intervention
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Measured: Follow-up at 1 week
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Measured: Baseline
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Measured: after intervention
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Measured: Follow-up at 1 week
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Measured: Baseline
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Measured: after intervention
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Measured: Follow-up at 1 week
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Measured: Baseline
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Measured: after intervention
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Measured: Follow-up at 1 week
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Measured: Baseline
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Measured: after intervention
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Measured: Follow-up at 1 week
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm.
The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth.
Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Measured: Baseline
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm.
The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth.
Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Measured: after intervention
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm.
The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth.
Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Measured: Follow-up at 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jun 2024
- Study start31 Aug 2024
- Primary completion30 Sep 2025
- Study completion30 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neck PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- CEU San Pablo University
- Sponsor type
- University, hospital or other
- Collaborators
- Universidad Católica de Ávila
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06480851
- Sponsor's protocol ID
- CEU-026
- Status last verified
- Jan 2026
- First submitted
- 3 Feb 2024
- Last updated
- 28 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Percutaneous Neuromodulation in the Treatment of Cervical Pain in University Students.
- ClinicalTrials.gov ID
- NCT06480851
- Acronym / sponsor ID
- CEU-026
- Conditions
- Neck Pain
- Keywords
- pain, Ecoguided Percutaneous Neuromodulation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 52 participants (actual)
- Lead sponsor
- CEU San Pablo UniversityUniversity, hospital or other
- Collaborators
- Universidad Católica de Ávila
- Study start
- 31 Aug 2024 (actual)
- Primary completion
- 30 Sep 2025 (actual)
- Study completion
- 30 Nov 2025 (actual)
- First posted
- 28 Jun 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A non-randomized experimental study will be conducted to investigate the effect of Ecoguided Percutaneous Neuromodulation on patients with and without neck pain in college students. The sample will be collected in a non-probabilistic way at convenience among the students at the San Pablo-CEU University, with a sample that will be divided into two groups: group 1 (G1) with neck pain and group 2 (G2).
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Neck Pain Group | Experimental | Procedure: Ecoguided Percutaneous Neuromodulation |
| Non Neck Pain Group | Active comparator | Procedure: Ecoguided Percutaneous Neuromodulation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Current Cervical Pain on a Visual Analog Scale (VAS) greater than 3.
- Neck pain in the last 12 weeks, and no treatment has been performed.
- Disability index of 8% or more on the Neck Disability Index.
- That they have undergone treatment.
Key exclusion criteria (8 listed)
- Neck pain associated with vertigo.
- Osteoporosis (control X-ray).
- Diagnosed psychological disorders.
- Vertebral fractures (control X-ray).
- Tumors.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ecoguided Percutaneous NeuromodulationEcoguided Percutaneous Neuromodulation over the posterior branch of the cervical multifidus, for 10 minutes, with a frequency of 10 HZ. | Procedure or surgery | Neck Pain Group, Non Neck Pain Group |
Primary outcome
Pain threshold
Time frame: up to 1 Week
Portable hand pressure algometer (FPX 50/220, Wagner Instruments, Greenwich, USA), measured in kg / cm² (kilogram per centimeter squared).
18 secondary outcomes
Pain by visual analog scale
Time frame: Baseline
Pain by visual analog scale
Time frame: after intervention
Pain by visual analog scale
Time frame: Follow-up at 1 week
Neck Disability Index Questionnaire.
Time frame: Baseline
Neck Disability Index Questionnaire.
Time frame: after intervention
Neck Disability Index Questionnaire.
Time frame: Follow-up at 1 week
Kinesiophobia
Time frame: Baseline
Kinesiophobia
Time frame: after intervention
Kinesiophobia
Time frame: Follow-up at 1 week
Pain Catastrophizing Scale
Time frame: Baseline
Pain Catastrophizing Scale
Time frame: after intervention
Pain Catastrophizing Scale
Time frame: Follow-up at 1 week
Health-related quality of life
Time frame: Baseline
Health-related quality of life
Time frame: after intervention
Health-related quality of life
Time frame: Follow-up at 1 week
Sonoelastography
Time frame: Baseline
Sonoelastography
Time frame: after intervention
Sonoelastography
Time frame: Follow-up at 1 week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Neck Pain
Not yet recruiting
Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain
Nonspecific Low Back Pain
Recruiting
Strain Counter Strain and Conventional Stretching in School-aged Children With Mechanical Neck Pain Due to Prolong Screen Use
Mechanical Neck Pain
Recruiting
Effects of Alexander Technique Versus Feldenkrais Somatic Training in Patients With Text Neck Syndrome
Text Neck Syndrome
Recruiting
Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.
Chronic Neck Pain
RecruitingPhase 2
Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot Study
Cancer Pain, Orofacial Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ecoguided Percutaneous Neuromodulation in people with Neck Pain, run by CEU San Pablo University at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain threshold (time frame: up to 1 Week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.